AKI Arthro Kinetics

    RNS Number : 5437E
  Arthro Kinetics plc
  29 September 2008
   

    29 September 2008

    Arthro Kinetics plc (the "Company")

    Further to the announcement made earlier today, the Company confirms that it is in preliminary discussions which may or may not lead to
an offer for the issued share capital of the Company.

    A further announcement will be made in due course.

    Enquiries:

    Arthro Kinetics plc                                      Tel: +49 (0)711 305 110 70
    Jason Loveridge (Chief Executive)
    Doug Quinn (Finance Director)

    Nomura Code Securities Limited                 Tel: +44 (0)20 7776 1200
    Richard Potts/Giles Balleny     



    The City Code on Takeovers and Mergers (the "City Code")

    1) Rule 2.10 of the City Code

    In accordance with Rule 2.10 of the City Code, the Company confirms that it has 88,003,166 ordinary shares of 5p each in issue under the
ISIN code GB00BOXQ4466. 

    2) Dealing Disclosure Requirements 

    Under the provisions of Rule 8.3 of the City Code, if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of
any class of "relevant securities" of Arthro Kinetics plc, all "dealings" in any "relevant securities" of that company (including by means
of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30
pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on
which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period"
otherwise ends. 

    If two or more persons act together pursuant to an agreement or understanding, whether
    formal or informal, to acquire an "interest" in "relevant securities" of Arthro Kinetics plc, they will be deemed to be a single person
for the purpose of Rule 8.3.

    Under the provisions of Rule 8.1 of the City Code, all "dealings" in "relevant securities" of Arthro Kinetics plc by Arthro Kinetics
plc, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day
following the date of the relevant transaction.

    A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of
such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

    "Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in
the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of
securities, or by virtue of any option in respect of, or derivative referenced to, securities.

    Terms in quotation marks are defined in the City Code, which can also be found on the Panel's website. If you are in any doubt as to
whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel."


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
OFDBGGDCXBDGGIC

Arthro Kinetics (LSE:AKI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Arthro Kinetics (LSE:AKI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024